CLASS II Device recall · Reported 19 Sep 2018 · FDA Enforcement Report

AnastoClip GC Closure System recalled by LeMaitre Vascular

LeMaitre Vascular is recalling AnastoClip GC Closure System, distributed in Florida, Nevada, Oklahoma, South Carolina, Texas. The recall was initiated on 19 Jun 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAGC2134
Quantity recalledN/A

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-3042-2018
FDA event ID
80627
Recalling firm
LeMaitre Vascular, Burlington, MA
Classification
Class II
Status
Terminated
Recall initiated
19 Jun 2018
FDA classified
13 Sep 2018
Reported
19 Sep 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

19 Jun 2018Recall initiated by company
13 Sep 2018Classified by FDA+86 days
19 Sep 2018Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The wrong instructions for use (IFU) were supplied with the AnastoClip GC closure system. The IFU provided lists some indications which are not cleared by the FDA for devices distributed in the United States: 1) closure of arteriotomies and veinotomies, 2) attachment of synthetic vascular prostheses, and 3) approximation of dural tissue.

Product as listed by the FDA

AnastoClip GC Closure System, REF# 4007-08 a closure system designed to penetrate the outer layers of tissue during the forming of an anastomosis or closing of a vessel with possible intraluminal penetration.

Where it was distributed

Distributed to accounts in FL, NV, OK, SC, and TX.

FloridaNevadaOklahomaSouth CarolinaTexas

Questions about this recall

Why was it recalled?

The wrong instructions for use (IFU) were supplied with the AnastoClip GC closure system. The IFU provided lists some indications which are not cleared by the FDA for devices distributed in the United States: 1) closure of arteriotomies and veinotomies, 2) attachment of synthetic vascular prostheses, and 3) approximation of dural tissue.

Which lots are affected?

AGC2134

Where was it sold?

Distributed to accounts in FL, NV, OK, SC, and TX.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from LeMaitre Vascular

All 70

Other Other Medical Devices recalls

All 13,778